Insight Molecular Diagnostics (IMDX) Gross Margin (2020 - 2026)
Insight Molecular Diagnostics (IMDX) posted Gross Margin of 46.88% for Q1 2026, up 7.64% sequentially from 43.55% in Q4 2025, and down 1510.0% YoY from 3.32% in Q1 2025.
Insight Molecular Diagnostics (IMDX) Gross Margin (2020 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 7 years of Gross Margin data on file, last reported at 46.88% in Q1 2026.
- Quarterly Gross Margin fell 1510.0% year-over-year to 46.88% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 51.31% (down 125.0% YoY) and the FY2025 annual result came in at 56.67%, up 1733.0% from the prior year.
- Gross Margin climbed to 46.88% in Q1 2026 per IMDX's latest filing, from 43.55% in the prior quarter.
- The five-year high for Gross Margin was 67.57% in Q2 2025, with the low at 401.49% in Q3 2022.
- Average Gross Margin over 5 years is 10.59%, with a median of 43.55% recorded in 2025.
- Year-over-year, Gross Margin plunged 31348 bps in 2022 and jumped 45930 bps in 2023.
- Insight Molecular Diagnostics' Gross Margin stood at 9.85% in 2022, then slumped by 278 bps to 37.26% in 2023, then surged by 207 bps to 40.04% in 2024, then grew by 9 bps to 43.55% in 2025, then increased by 8 bps to 46.88% in 2026.
- Business Quant data shows IMDX's Gross Margin at 46.88% in Q1 2026, 43.55% in Q4 2025, and 53.46% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 87.77% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 70.37% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 60.34% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 63.35% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 99.91% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 53.95% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 32.64% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 66.09% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 58.68% |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 46.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.88% |
| Dec 31, 2025 | 43.55% |
| Sep 30, 2025 | 53.46% |
| Jun 30, 2025 | 67.57% |
| Mar 31, 2025 | 61.97% |
| Dec 31, 2024 | 40.04% |
| Sep 30, 2024 | 43.48% |
| Jun 30, 2024 | 48.08% |
| Mar 31, 2024 | 25.57% |
| Dec 31, 2023 | -37.26% |
| Sep 30, 2023 | 57.81% |
| Jun 30, 2023 | 58.75% |
| Mar 31, 2023 | 3.37% |
| Dec 31, 2022 | -9.85% |
| Sep 30, 2022 | -401.49% |
| Jun 30, 2022 | 13.08% |
| Mar 31, 2022 | 65.00% |
| Dec 31, 2021 | 72.47% |
| Sep 30, 2021 | -88.01% |
| Jun 30, 2021 | -19.41% |